JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description:BCX 1470 methanesulfonate is a novel, potent and selective Serine protease inhibitorthat inhibits the esterolytic activity of factor D (IC50=96 nM) and C1s(IC50=1.6 nM), 3.4- and 200-fold better, respectively, than that oftrypsin. . CX 1470 blocks the esterolytic and hemolytic activities ofthe complement enzymes Cls and factor D in vitro, also blockeddevelopment of RPA-induced edema in the rat. BCX 1470 may be useful asan anti-inflammatory agent in diseases where complement activation isknown to be detrimental.
References: The Arthus Reaction in Rodents: Species-Specific Requirement of ComplementJournal of Immunology, 2000, 164, 463-468
Related CAS#: 217099-43-9 (free base)
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!